Clinical case series describes a contraindication for SerenoCem Granules™ in mastoid obliteration: Our experience in sixty‐four patients. (28th May 2017) - Harrison, L.; Kumar, S.; Bull, M.; Hatton, P.V.; Bottrill, I.; Aldren, C.